Antibody response to inactivated influenza vaccine given by different routes in patients with chronic bronchopulmonary disease.
D000281:Administration, Intranasal; D000284:Administration, Oral; D000336:Aerosols; D000402:Airway Obstruction / Q000276:immunology*; D000914:Antibodies, Viral / Q000032:analysis; D000917:Antibody Formation; D001249:Asthma / Q000276:immunology*; D001798:Blood Proteins / Q000032:analysis; D001991:Bronchitis / Q000276:immunology*; D002908:Chronic Disease; D005260:Female; D006801:Humans; D007252:Influenza Vaccines / Q000008:administration & dosage*; D007279:Injections, Subcutaneous; D008297:Male; D008875:Middle Aged; D013183:Sputum / Q000032:analysis / Q000382:microbiology
D000336:Aerosols; D000914:Antibodies, Viral; D001798:Blood Proteins; D007252:Influenza Vaccines